The average star ratings for Medicare Advantage plans with prescription drug coverage and Part D plans were 4.15 and 3.25, which marked decreases from last year, the 2023 Medicare Advantage Star...
Medicare Part B premiums and deductibles will decrease in 2023, while Part A costs will rise, according to a fact sheet released by CMS.
Medicare Part B offers coverage for physician services,...
With Medicare spending increasing, finding both short- and long-term solutions for Medicare financing is imperative, an issue brief from Urban Institute found.
“With Medicare spending growing...
Senate Finance Committee Chair Ron Wyden (D-Ore.) has inquired about potentially deceptive marketing practices by Medicare Advantage plans that exploit seniors and people with...
While the Inflation Reduction Act of 2022 will likely improve member retention and curb healthcare costs for enrollees in the individual market, the impact on the employer market is less clear. As Medicare negotiates lower drug prices,...
Under Medicare Part D, more than half of the beneficiaries were liable for paying the entire out-of-pocket cost of their generic prescription drug, according to an analysis from Avalere.
Avalere...
The number of Medicare beneficiaries enrolled in the Medicare Savings Programs and receiving Part D low-income subsidies varied by state, as states have the individual power to expand eligibility and...
Applying an out-of-pocket spending cap to Medicare Part D could be a tool for promoting health equity, according to an insight from Avalere.
Avalere researchers leveraged 2019 Medicare Part D Drug...
Out-of-pocket costs may dissuade Medicare beneficiaries from initiating treatment with high-price Part D specialty drugs, as beneficiaries without low-income subsidies were less likely to fill a new...
Policymakers should consider increasing access to and promoting the use of biosimilars and monitoring trends in biosimilar coverage in order to bring down Medicare Part D spending, the Office of...
Medicare coverage for antiretroviral therapy (ART) did not improve overall spending for Medicare beneficiaries with HIV, but the therapy did appear to positively impact spending outside of HIV...
CMS announced an 8.5 percent boost on average to payer revenues next year in the 2023 Medicare Advantage and Part D Rate, according to a CMS press release.
This final rate announcement was higher than...
In the 2023 Medicare Advantage and Part D Advance Notice, CMS is requesting comments on the agency’s health equity index which it seeks to introduce into Part D and Medicare Advantage Star...
CMS released the calendar year 2023 Medicare Advantage and Part D proposed rule which aims to improve network adequacy, elucidate medical loss ratio reporting, open the possibility of assigning star...
Zero-dollar health plans are bringing average Medicare Advantage premiums lower, continuing an ongoing trend, an eHealth report found.
eHealth surveyed over 4,200 Medicare beneficiaries who were...
The Build Back Better Act includes measures that aim to reduce Medicare Part D drug spending and bolster the ability for both Medicare Part D plans and potentially private payers to control drug...
Medicare Advantage has seen a lot of growth in recent years and that trend is set to continue into 2022, as evident in the number of plan offerings for the Medicare Advantage 2022 open enrollment...
Most Medicare beneficiaries did not review their health plan options during open enrollment in 2018, according to a Kaiser Family Foundation (KFF) issue brief.
“The marketplace of Medicare...
Over nine in ten Medicare Advantage-prescription drug plans (94.26 percent) received a 3.5 star rating or higher on the 2022 Medicare Advantage Star Ratings, with an average star rating of 4.37 stars,...
As the 2022 Medicare Advantage open enrollment period approaches, payers are revealing their 2022 Medicare Advantage benefits.
Five major payers shared the updates to their benefit offerings for the...
